Guggulu (Commiphora mukul)

Guggulu (Commiphora mukul) is not consumed as a food source and therefore lacks a conventional nutritional profile of macronutrients. It is valued entirely for its bioactive resinous compounds. Key Bioactive Compounds: • Guggulsterones (E- and Z-isomers): The primary pharmacologically active steroids, typically comprising ~1.0–5.0% of purified guggul resin (shuddha guggulu). Z-guggulsterone is generally considered the more bioactive isomer. These are C21 steroidal ketones derived from the pregnane skeleton. • Guggulipid (standardized extract): Commercially standardized to contain ~2.5–5% guggulsterones (combined E and Z forms). • Myrrhanol A and Myrrhanone A: Polypodane-type triterpenes found in smaller quantities. • Mukulol (Z-guggulsterol): A sterol present at ~0.2–0.5% of oleo-gum-resin. • Guggulignan I and II: Lignan compounds with reported antioxidant activity. • Essential oils: ~1.0–1.6% of crude oleo-gum-resin, containing eugenol, d-limonene, cineol, and sesquiterpenoids (including α-bisabolene and β-caryophyllene). • Polysaccharides (gum fraction): ~30–60% of crude resin; composed of arabinose, galactose, mannose, glucuronic acid, and 4-O-methylglucuronic acid residues; primarily structural/carrier, not directly bioactive. • Phenolic acids: Gallic acid (~0.05–0.2%), ellagic acid (trace to ~0.1%), and ferulic acid (trace amounts), contributing antioxidant properties. • Diterpenoids: Cembrene, cembrene A, and mukulol present in small fractions. • Minerals (trace in crude resin): Iron, manganese, zinc, and calcium in low, variable concentrations (not standardized). • Resin fraction: ~25–40% of crude material; contains steroidal and triterpenoid compounds. Bioavailability Notes: Guggulsterones have relatively low oral bioavailability due to poor aqueous solubility and significant first-pass hepatic metabolism. Studies in animal models suggest bioavailability of ~~30–40% for oral guggulsterone. Ayurvedic processing (shodhana, or purification with Triphala decoction, cow's milk, or cow's urine) is traditionally believed to enhance efficacy, and there is preliminary evidence that purification may alter the resin's chemical composition and reduce toxic diterpene content. Lipid-based formulations and nano-encapsulation have been explored to improve absorption. The gum fraction may modulate release kinetics. Co-administration with piperine (from black pepper, common in Ayurvedic polyherbal formulations) may enhance bioavailability by inhibiting glucuronidation.